IBB iShares Biotechnology ETF
206.49
6.01 (+3.00%)
気配値取得時刻： Oct 09, 2026 20:00 UTC · Market data delayed approximately 15–20 minutes unless otherwise indicated.
このETFについて
The iShares Biotechnology ETF (IBB) is designed to mirror the investment performance of a specific market index. This index comprises publicly traded stocks from companies operating within the U.S. biotechnology sector.
ファンドデータプロバイダーによる説明 · 基準日時点のプロファイル： Oct 10, 2026.
価格チャート
日次終値（価格リターン、トータルリターンではありません）。比較ラインは期間開始時点からの変化率に正規化されています。 出所: Financial Modeling Prep.
パフォーマンス
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | 設定日* | |
|---|---|---|---|---|---|---|---|---|---|
| 価格リターン | +0.49% | +7.51% | +21.92% | +22.35% | +35.80% | +18.85% | +5.89% | +8.39% | +7.22% |
| トータルリターン | +0.49% | +7.51% | +21.93% | +22.45% | +36.07% | +19.14% | +6.16% | +8.67% | +7.41% |
* 年率換算。トータルリターンは配当調整済み価格シリーズ（分配金再投資）、価格リターンは調整前終値を使用しています。 基準日時点のパフォーマンス Oct 09, 2026. 過去の運用実績は将来の結果を保証するものではありません。
手数料
| 実質信託報酬 | 0.44% | 1万ドル投資した場合の年間コスト | $44.00 |
あくまで試算です（経費率×10,000ドル）。売買コスト・ビッド/アスクスプレッド・税金・運用損益は含まれません。グロス/ネット経費率の詳細および手数料免除については目論見書をご確認ください。
保有銘柄一覧
保有銘柄基準日： Oct 10, 2026 · データプロバイダーによるポートフォリオ報告日。保有銘柄はリアルタイムのポジションではありません。 246 データベース内の行数.
| # | 保有銘柄 | ティッカー | ウェイト | 株式 | 時価総額 |
|---|---|---|---|---|---|
| 1 | GILEAD SCIENCES | GILD | 8.37% | 5.99M | $880.7M |
| 2 | AMGEN INC | AMGN | 7.89% | 2.04M | $829.9M |
| 3 | VERTEX PHARMACEUTICALS | VRTX | 7.69% | 1.61M | $809.4M |
| 4 | REGENERON PHARMACEUTICALS | REGN | 5.40% | 768.03K | $568.0M |
| 5 | MODERNA | MRNA | 5.30% | 2.83M | $557.7M |
| 6 | NATERA | NTRA | 3.88% | 1.04M | $407.7M |
| 7 | ARGENX SE ADR | ARGX | 3.35% | 430.72K | $352.6M |
| 8 | ILLUMINA INC | ILMN | 2.94% | 1.17M | $308.8M |
| 9 | REVOLUTION MEDICINES | RVMD | 2.67% | 1.49M | $281.1M |
| 10 | BIOGEN | BIIB | 2.36% | 1.14M | $248.2M |
| 11 | ALNYLAM PHARMACEUTICALS | ALNY | 2.21% | 1.03M | $232.1M |
| 12 | BEONE MEDICINES AG | ONC | 2.17% | 652.02K | $228.3M |
| 13 | INCYTE CORP | INCY | 1.67% | 1.56M | $175.6M |
| 14 | UNITED THERAPEUTICS | UTHR | 1.63% | 321.29K | $171.2M |
| 15 | INSMED | INSM | 1.59% | 1.67M | $167.5M |
| 16 | GENMAB SPONSORED ADR | GMAB | 1.47% | 4.29M | $154.8M |
| 17 | ROIVANT SCIENCES LTD | ROIV | 1.32% | 4.06M | $139.0M |
| 18 | NEUROCRINE BIOSCIENCES | NBIX | 1.05% | 778.83K | $110.0M |
| 19 | EXELIXIS INC | EXEL | 1.04% | 1.86M | $109.7M |
| 20 | CHARLES RIVER LABORATORIES INTERNA | CRL | 1.04% | 365.89K | $109.0M |
| 21 | ASCENDIS PHARMA | ASND | 1.01% | 477.86K | $106.4M |
| 22 | MEDPACE HOLDINGS | MEDP | 1.00% | 174.16K | $105.0M |
| 23 | HALOZYME THERAPEUTICS | HALO | 0.91% | 870.26K | $95.6M |
| 24 | BRIDGEBIO PHARMA | BBIO | 0.84% | 1.36M | $88.3M |
| 25 | BIO TECHNE | TECH | 0.83% | 1.21M | $87.6M |
| 26 | BIOMARIN PHARMACEUTICAL | BMRN | 0.77% | 1.48M | $81.3M |
| 27 | MADRIGAL PHARMACEUTICALS | MDGL | 0.76% | 166.76K | $79.5M |
| 28 | TWIST BIOSCIENCE | TWST | 0.71% | 494.14K | $75.1M |
| 29 | VAXCYTE | PCVX | 0.70% | 1.13M | $73.3M |
| 30 | 10X GENOMICS CLASS A | TXG | 0.66% | 898.56K | $69.4M |
| 31 | BIONTECH SE ADR | BNTX | 0.65% | 741.82K | $68.3M |
| 32 | REPLIGEN | RGEN | 0.64% | 413.05K | $67.7M |
| 33 | PROTAGONIST THERAPEUTICS | PTGX | 0.63% | 474.33K | $66.4M |
| 34 | KRYSTAL BIOTECH | KRYS | 0.62% | 200.76K | $65.7M |
| 35 | CYTOKINETICS | CYTK | 0.61% | 1.03M | $64.1M |
| 36 | KYMERA THERAPEUTICS | KYMR | 0.60% | 578.65K | $63.2M |
| 37 | ARROWHEAD PHARMACEUTICALS | ARWR | 0.59% | 1.03M | $62.6M |
| 38 | AXSOME THERAPEUTICS | AXSM | 0.55% | 341.32K | $58.1M |
| 39 | TEMPUS AI CLASS A | TEM | 0.55% | 834.37K | $57.8M |
| 40 | IONIS PHARMACEUTICALS | IONS | 0.52% | 1.26M | $54.7M |
| 41 | PRAXIS PRECISION MEDICINES | PRAX | 0.51% | 203.49K | $53.6M |
| 42 | ALKERMES | ALKS | 0.48% | 1.26M | $50.6M |
| 43 | ABIVAX AMERICAN DEPOSITARY SHARES | ABVX | 0.48% | 563.19K | $50.2M |
| 44 | BRUKER | BRKR | 0.47% | 860.26K | $49.8M |
| 45 | SPYRE THERAPEUTICS INC | SYRE | 0.47% | 612.44K | $48.9M |
| 46 | RHYTHM PHARMACEUTICALS | RYTM | 0.44% | 512.37K | $45.9M |
| 47 | GRAIL INC | GRAL | 0.41% | 326.70K | $43.3M |
| 48 | KODIAK SCIENCES | KOD | 0.40% | 450.62K | $42.5M |
| 49 | IOVANCE BIOTHERAPEUTICS INC | IOVA | 0.39% | 3.05M | $40.6M |
| 50 | PTC THERAPEUTICS | PTCT | 0.37% | 617.88K | $38.7M |
| 51 | TRAVERE THERAPEUTICS | TVTX | 0.35% | 708.05K | $36.8M |
| 52 | COGENT BIOSCIENCES | COGT | 0.34% | 1.21M | $36.3M |
| 53 | ORUKA THERAPEUTICS INC | ORKA | 0.33% | 455.84K | $35.2M |
| 54 | CRISPR THERAPEUTICS AG | CRSP | 0.33% | 695.77K | $35.1M |
| 55 | DEFINIUM THERAPEUTICS INC | DFTX | 0.32% | 993.63K | $34.0M |
| 56 | MIRUM PHARMACEUTICALS | MIRM | 0.32% | 411.57K | $33.5M |
| 57 | SCHOLAR ROCK HOLDING | SRRK | 0.31% | 769.61K | $32.5M |
| 58 | ADAPTIVE BIOTECHNOLOGIES | ADPT | 0.30% | 1.20M | $31.3M |
| 59 | IMMUNITYBIO | IBRX | 0.29% | 3.05M | $30.2M |
| 60 | ERASCA | ERAS | 0.28% | 1.91M | $29.5M |
| 61 | CG ONCOLOGY | CGON | 0.27% | 454.29K | $28.7M |
| 62 | CARIS LIFE SCIENCES | CAI | 0.26% | 984.36K | $27.1M |
| 63 | VERACYTE | VCYT | 0.25% | 610.71K | $26.6M |
| 64 | ACADIA PHARMACEUTICALS | ACAD | 0.25% | 1.32M | $25.8M |
| 65 | XENON PHARMACEUTICALS | XENE | 0.24% | 711.40K | $25.7M |
| 66 | IDEAYA BIOSCIENCES | IDYA | 0.24% | 702.89K | $25.3M |
| 67 | EDGEWISE THERAPEUTICS | EWTX | 0.24% | 633.04K | $24.8M |
| 68 | TANGO THERAPEUTICS | TNGX | 0.23% | 1.08M | $24.4M |
| 69 | LEGEND BIOTECH ADR REP | LEGN | 0.23% | 1.27M | $23.8M |
| 70 | ABCELLERA BIOLOGICS | ABCL | 0.22% | 1.93M | $23.2M |
| 71 | RELAY THERAPEUTICS | RLAY | 0.22% | 1.33M | $23.1M |
| 72 | TARSUS PHARMACEUTICALS | TARS | 0.22% | 319.78K | $23.1M |
| 73 | CAREDX | CDNA | 0.22% | 366.68K | $22.8M |
| 74 | AMYLYX PHARMACEUTICALS | AMLX | 0.21% | 823.24K | $22.4M |
| 75 | DENALI THERAPEUTICS | DNLI | 0.21% | 1.16M | $21.7M |
| 76 | ARCUTIS BIOTHERAPEUTICS | ARQT | 0.20% | 847.97K | $20.8M |
| 77 | SUMMIT THERAPEUTICS | SMMT | 0.19% | 1.18M | $20.3M |
| 78 | IMMUNOVANT | IMVT | 0.19% | 654.75K | $19.8M |
| 79 | DYNE THERAPEUTICS | DYN | 0.18% | 1.19M | $19.5M |
| 80 | ENLIVEN THERAPEUTICS | ELVN | 0.18% | 470.06K | $19.1M |
| 81 | ZAI LABORATORY ADR REPRESENTING LT | ZLAB | 0.17% | 735.59K | $18.2M |
| 82 | BEAM THERAPEUTICS | BEAM | 0.17% | 727.95K | $17.9M |
| 83 | ADMA BIOLOGICS | ADMA | 0.16% | 1.66M | $17.2M |
| 84 | NURIX THERAPEUTICS | NRIX | 0.16% | 766.08K | $17.0M |
| 85 | VERICEL | VCEL | 0.15% | 392.13K | $15.7M |
| 86 | ARCUS BIOSCIENCES | RCUS | 0.15% | 658.55K | $15.7M |
| 87 | FORTREA HOLDINGS INC | FTRE | 0.14% | 729.61K | $14.9M |
| 88 | AURINIA PHARMACEUTICALS | AUPH | 0.14% | 911.60K | $14.8M |
| 89 | RECURSION PHARMACEUTICALS CLASS A | RXRX | 0.14% | 3.69M | $14.6M |
| 90 | AGIOS PHARMACEUTICALS | AGIO | 0.14% | 451.53K | $14.4M |
| 91 | SAREPTA THERAPEUTICS | SRPT | 0.14% | 782.51K | $14.2M |
| 92 | BIOCRYST PHARMACEUTICALS | BCRX | 0.13% | 1.70M | $14.1M |
| 93 | ZYMEWORKS | ZYME | 0.13% | 534.54K | $13.5M |
| 94 | VERA THERAPEUTICS CLASS A | VERA | 0.13% | 453.11K | $13.5M |
| 95 | NOVAVAX | NVAX | 0.13% | 1.21M | $13.4M |
| 96 | DISC MEDICINE | IRON | 0.13% | 219.73K | $13.4M |
| 97 | GRIFOLS ADR REPRESENTING ONE NON-V | GRFS | 0.13% | 1.80M | $13.3M |
| 98 | XENCOR | XNCR | 0.13% | 542.34K | $13.3M |
| 99 | INTELLIA THERAPEUTICS | NTLA | 0.12% | 1.04M | $13.1M |
| 100 | NEWAMSTERDAM PHARMA | NAMS | 0.12% | 599.09K | $12.7M |
| 101 | BLK CSH FND TREASURY SL AGENCY | — | 0.12% | 12.64M | $12.6M |
| 102 | MBX BIOSCIENCES | MBX | 0.12% | 236.39K | $12.6M |
| 103 | STRUCTURE THERAPEUTICS ADR | GPCR | 0.12% | 478.28K | $12.3M |
| 104 | UROGEN PHARMA | URGN | 0.11% | 321.65K | $11.9M |
| 105 | BIOHAVEN | BHVN | 0.11% | 995.92K | $11.9M |
| 106 | VIR BIOTECHNOLOGY | VIR | 0.11% | 1.04M | $11.5M |
| 107 | NOVOCURE | NVCR | 0.11% | 811.25K | $11.5M |
| 108 | UNIQURE | QURE | 0.11% | 499.57K | $11.3M |
| 109 | SYNDAX PHARMACEUTICALS | SNDX | 0.10% | 632.70K | $10.7M |
| 110 | ULTRAGENYX PHARMACEUTICAL | RARE | 0.10% | 696.86K | $10.7M |
| 111 | MINERALYS THERAPEUTICS | MLYS | 0.10% | 469.95K | $10.5M |
| 112 | ABSCI CORP | ABSI | 0.10% | 1.15M | $10.2M |
| 113 | IMMUNOCORE HOLDINGS ADR PLC | IMCR | 0.10% | 351.21K | $10.2M |
| 114 | COMPASS PATHWAYS ADR PLC | CMPS | 0.10% | 880.80K | $10.1M |
| 115 | LAKEFRONT BIOTHERAPEUTICS ADR NV | LKFT | 0.09% | 336.85K | $9.9M |
| 116 | STOKE THERAPEUTICS | STOK | 0.09% | 414.67K | $9.9M |
| 117 | ANAPTYSBIO | ANAB | 0.09% | 214.27K | $9.9M |
| 118 | PRECIGEN | PGEN | 0.09% | 1.27M | $9.7M |
| 119 | NUVATION BIO CLASS A | NUVB | 0.09% | 1.95M | $9.6M |
| 120 | TREVI THERAPEUTICS | TRVI | 0.09% | 746.85K | $9.6M |
| 121 | TAYSHA GENE THERAPIES | TSHA | 0.09% | 2.05M | $9.1M |
| 122 | PERSONALIS | PSNL | 0.09% | 557.85K | $9.0M |
| 123 | REPLIMUNE GROUP | REPL | 0.08% | 677.79K | $8.8M |
| 124 | SEPTERNA | SEPN | 0.08% | 226.15K | $8.3M |
| 125 | JANUX THERAPEUTICS | JANX | 0.08% | 448.74K | $8.3M |
| 126 | TYRA BIOSCIENCES | TYRA | 0.08% | 409.11K | $8.2M |
| 127 | MANNKIND | MNKD | 0.08% | 2.38M | $8.1M |
| 128 | GH RESEARCH PLC | GHRS | 0.08% | 394.47K | $8.1M |
| 129 | PHARVARIS N V | PHVS | 0.08% | 256.22K | $8.0M |
| 130 | INHIBRX BIOSCIENCES INC | INBX | 0.08% | 85.17K | $7.9M |
| 131 | CASTLE BIOSCIENCES | CSTL | 0.07% | 232.78K | $7.8M |
| 132 | MESOBLAST ADR REPRESENTING | MESO | 0.07% | 569.81K | $7.8M |
| 133 | ALVOTECH SA | ALVO | 0.07% | 1.35M | $7.6M |
| 134 | STEVANATO GROUP | STVN | 0.07% | 385.26K | $7.4M |
| 135 | KURA ONCOLOGY | KURA | 0.07% | 673.95K | $7.1M |
| 136 | ZENAS BIOPHARMA | ZBIO | 0.07% | 264.62K | $6.9M |
| 137 | MAZE THERAPEUTICS | MAZE | 0.07% | 265.53K | $6.9M |
| 138 | RIGEL PHARMACEUTICALS | RIGL | 0.07% | 140.69K | $6.9M |
| 139 | ALTO NEUROSCIENCE INC | ANRO | 0.06% | 277.49K | $6.7M |
| 140 | RAPPORT THERAPEUTICS | RAPP | 0.06% | 222.64K | $6.6M |
| 141 | ORIC PHARMACEUTICALS | ORIC | 0.06% | 528.51K | $6.4M |
| 142 | MARAVAI LIFESCIENCES HOLDINGS INC | MRVI | 0.06% | 859.12K | $6.2M |
| 143 | GERON | GERN | 0.06% | 4.92M | $6.0M |
| 144 | MEIRAGTX HOLDINGS PLC | MGTX | 0.06% | 564.33K | $5.9M |
| 145 | BICARA THERAPEUTICS INC | BCAX | 0.06% | 336.25K | $5.8M |
| 146 | CULLINAN THERAPEUTICS | CGEM | 0.05% | 364.96K | $5.6M |
| 147 | ALUMIS | ALMS | 0.05% | 746.65K | $5.2M |
| 148 | PACIFIC BIOSCIENCES OF CALIFORNIA | PACB | 0.05% | 2.26M | $5.2M |
| 149 | ARBUTUS BIOPHARMA CORP | ABUS | 0.05% | 1.24M | $5.2M |
| 150 | ANNEXON | ANNX | 0.05% | 1.28M | $5.1M |
| 151 | ZEVRA THERAPEUTICS INC | ZVRA | 0.05% | 460.69K | $5.1M |
| 152 | CORVUS PHARMACEUTICALS | CRVS | 0.05% | 496.04K | $5.1M |
| 153 | CYTEK BIOSCIENCES | CTKB | 0.05% | 938.16K | $5.0M |
| 154 | 4D MOLECULAR THERAPEUTICS INC | FDMT | 0.05% | 388.31K | $4.9M |
| 155 | IRONWOOD PHARMA CLASS A | IRWD | 0.05% | 1.25M | $4.8M |
| 156 | MONTE ROSA THERAPEUTICS | GLUE | 0.05% | 459.44K | $4.7M |
| 157 | SOLID BIOSCIENCES INC | SLDB | 0.04% | 664.65K | $4.5M |
| 158 | CANDEL THERAPEUTICS INC | CADL | 0.04% | 469.04K | $4.5M |
| 159 | ARRIVENT BIOPHARMA | AVBP | 0.04% | 268.50K | $4.5M |
| 160 | WAVE LIFE SCIENCES INC | WVE | 0.04% | 1.25M | $4.3M |
| 161 | OMNIAB INC | OABI | 0.04% | 930.64K | $4.3M |
| 162 | GINKGO BIOWORKS HOLDINGS CLASS A | DNA | 0.04% | 375.82K | $4.3M |
| 163 | OLEMA PHARMACEUTICALS | OLMA | 0.04% | 544.55K | $4.3M |
| 164 | SANA BIOTECHNOLOGY | SANA | 0.04% | 1.43M | $4.0M |
| 165 | SAGIMET BIOSCIENCES SERIES A | SGMT | 0.04% | 444.99K | $4.0M |
| 166 | OPKO HEALTH | OPK | 0.04% | 2.82M | $3.9M |
| 167 | SAVARA | SVRA | 0.04% | 796.52K | $3.8M |
| 168 | REGENXBIO | RGNX | 0.04% | 472.85K | $3.8M |
| 169 | ALTIMMUNE INC | ALT | 0.04% | 1.46M | $3.8M |
| 170 | CYTOMX THERAPEUTICS | CTMX | 0.03% | 1.48M | $3.6M |
| 171 | ARVINAS | ARVN | 0.03% | 453.54K | $3.4M |
| 172 | AURA BIOSCIENCES | AURA | 0.03% | 515.51K | $3.4M |
| 173 | ACLARIS THERAPEUTICS | ACRS | 0.03% | 872.66K | $3.3M |
| 174 | NEUROGENE | NGNE | 0.03% | 123.55K | $3.3M |
| 175 | DESIGN THERAPEUTICS | DSGN | 0.03% | 267.48K | $3.1M |
| 176 | CONTINEUM THERAPEUTICS CLASS A | CTNM | 0.03% | 231.59K | $3.1M |
| 177 | EDITAS MEDICINE | EDIT | 0.03% | 1.07M | $3.0M |
| 178 | PROTHENA PLC | PRTA | 0.03% | 347.62K | $3.0M |
| 179 | MYRIAD GENETICS | MYGN | 0.03% | 684.59K | $2.9M |
| 180 | FULGENT GENETICS | FLGT | 0.03% | 136.36K | $2.8M |
| 181 | PHATHOM PHARMACEUTICALS | PHAT | 0.03% | 395.26K | $2.8M |
| 182 | SILENCE THERAPEUTICS ADR REPRESENT | SLN | 0.03% | 288.05K | $2.7M |
| 183 | ARCTURUS THERAPEUTICS HOLDINGS INC | ARCT | 0.03% | 208.67K | $2.7M |
| 184 | PRIME MEDICINE | PRME | 0.03% | 735.21K | $2.6M |
| 185 | ALLOGENE THERAPEUTICS | ALLO | 0.02% | 1.85M | $2.6M |
| 186 | ENANTA PHARMACEUTICALS INC | ENTA | 0.02% | 213.67K | $2.6M |
| 187 | ATEA PHARMACEUTICALS | AVIR | 0.02% | 501.37K | $2.6M |
| 188 | EMERGENT BIOSOLUTIONS | EBS | 0.02% | 376.96K | $2.6M |
| 189 | C4 THERAPEUTICS | CCCC | 0.02% | 870.36K | $2.5M |
| 190 | AUTOLUS THERAPEUTICS ADR PLC | AUTL | 0.02% | 1.33M | $2.4M |
| 191 | CABALETTA BIO | CABA | 0.02% | 1.14M | $2.2M |
| 192 | ARS PHARMACEUTICALS | SPRY | 0.02% | 485.08K | $2.2M |
| 193 | ROCKET PHARMACEUTICALS | RCKT | 0.02% | 830.36K | $2.2M |
| 194 | FULCRUM THERAPEUTICS | FULC | 0.02% | 572.34K | $2.1M |
| 195 | VANDA PHARMACEUTICALS INC | VNDA | 0.02% | 441.67K | $2.0M |
| 196 | STANDARD BIOTOOLS | LAB | 0.02% | 2.91M | $1.9M |
| 197 | PERSPECTIVE THERAPEUTICS | CATX | 0.02% | 698.17K | $1.9M |
| 198 | KYVERNA THERAPEUTICS | KYTX | 0.02% | 292.06K | $1.8M |
| 199 | LEXEO THERAPEUTICS | LXEO | 0.02% | 535.56K | $1.7M |
| 200 | IMMUNEERING CLASS A | IMRX | 0.02% | 446.10K | $1.7M |
| 201 | TECTONIC THERAPEUTIC | TECX | 0.02% | 73.06K | $1.7M |
| 202 | KEROS THERAPEUTICS | KROS | 0.02% | 140.97K | $1.6M |
| 203 | QUANTUM SI INC CLASS A | QSI | 0.02% | 1.31M | $1.6M |
| 204 | BIOAGE LABS | BIOA | 0.01% | 245.11K | $1.5M |
| 205 | LINEAGE CELL THERAPEUTICS INC | LCTX | 0.01% | 1.45M | $1.5M |
| 206 | UPSTREAM BIO | UPB | 0.01% | 281.05K | $1.3M |
| 207 | BRIDGEBIO ONCOLOGY THERAPEUTICS IN | BBOT | 0.01% | 370.85K | $1.3M |
| 208 | AC IMMUNE SA AG | ACIU | 0.01% | 475.00K | $1.2M |
| 209 | PEPGEN | PEPG | 0.01% | 491.75K | $1.2M |
| 210 | ADC THERAPEUTICS LTD | ADCT | 0.01% | 734.04K | $1.2M |
| 211 | BICYCLE THERAPEUTICS ADR PLC | BCYC | 0.01% | 289.66K | $1.1M |
| 212 | CODEXIS | CDXS | 0.01% | 788.85K | $1.1M |
| 213 | ANAVEX LIFE SCIENCES CORP | AVXL | 0.01% | 693.22K | $1.1M |
| 214 | PYXIS ONCOLOGY INC | PYXS | 0.01% | 528.89K | $1.1M |
| 215 | ENTRADA THERAPEUTICS | TRDA | 0.01% | 185.02K | $1.0M |
| 216 | SIONNA THERAPEUTICS | SION | 0.01% | 205.90K | $1.0M |
| 217 | LARIMAR THERAPEUTICS | LRMR | 0.01% | 372.41K | $1.0M |
| 218 | QUANTERIX | QTRX | 0.01% | 307.69K | $987.7K |
| 219 | CASH COLLATERAL USD SGAFT | — | 0.01% | 947.00K | $947.0K |
| 220 | VOYAGER THERAPEUTICS | VYGR | 0.01% | 382.26K | $905.9K |
| 221 | TENAYA THERAPEUTICS | TNYA | 0.01% | 1.64M | $890.1K |
| 222 | NOVABRIDGE BIOSCIENCES ADR | NBP | 0.01% | 648.95K | $889.1K |
| 223 | HUMACYTE INC | HUMA | 0.01% | 1.91M | $851.8K |
| 224 | LENZ THERAPEUTICS | LENZ | 0.01% | 211.80K | $747.7K |
| 225 | ALPHA TEKNOVA | TKNO | 0.01% | 84.70K | $714.9K |
| 226 | BLACK DIAMOND THERAPEUTICS INC | BDTX | 0.01% | 380.88K | $689.4K |
| 227 | LYELL IMMUNOPHARMA | LYEL | 0.00% | 59.37K | $521.9K |
| 228 | FOGHORN THERAPEUTICS | FHTX | 0.00% | 243.37K | $484.3K |
| 229 | JYONG BIOTECH LTD | MENS | 0.00% | 225.20K | $472.9K |
| 230 | AARDVARK THERAPEUTICS | AARD | 0.00% | 97.77K | $460.5K |
| 231 | GOSSAMER BIO | GOSS | 0.00% | 43.47K | $429.5K |
| 232 | CARIBOU BIOSCIENCES | CRBU | 0.00% | 689.79K | $331.9K |
| 233 | AKERO THERAPEUTICS CVR | — | 0.00% | 515.95K | $330.2K |
| 234 | CELLECTIS ADR REPRESENTING SA | CLLS | 0.00% | 244.78K | $306.0K |
| 235 | NEUMORA THERAPEUTICS INC | NMRA | 0.00% | 596.48K | $286.2K |
| 236 | USD CASH | — | 0.00% | 206.44K | $206.4K |
| 237 | IMMUTEP ADS REPRESENTING LTD | IMMP | 0.00% | 40.19K | $154.3K |
| 238 | CHINOOK THERAPEUTICS INC | — | 0.00% | 320.96K | $54.6K |
| 239 | ARCELLX INC CVR | — | 0.00% | 335.81K | $23.5K |
| 240 | CARTESIAN THERAPEUTICS INC | — | 0.00% | 7.50K | $1.9K |
| 241 | FUSION PHARMACEUTICALS INC CVR | — | 0.00% | 1.88K | $1.0K |
| 242 | CARGO THERAPEUTICS INC | — | 0.00% | 198.10K | $1.98 |
| 243 | THIRD HARMONIC BIO INC | THRD | 0.00% | 134.48K | $1.34 |
| 244 | AKOUOS CVRS Prvt | — | 0.00% | 157.09K | $1.57 |
| 245 | OMNIAB INC $12.50 VESTING Prvt | — | 0.00% | 46.84K | $0.47 |
| 246 | OMNIAB INC $15.00 VESTING Prvt | — | 0.00% | 46.84K | $0.47 |
ティッカーをクリックすると、そのティッカーを保有するすべてのETFが表示されます。
セクター配分
地域別エクスポージャー
国別ウェイトはデータプロバイダーの報告値に基づきます。先進国・新興国・フロンティアの区分は、方法論ページの分類に従います。 為替ヘッジあり: ファンド名にヘッジの記載なし.
分配金
| 利回り（TTM） | 0.16% | 支払済み（過去12か月） | $0.3399 |
| 頻度 | Quarterly | SEC利回り | データソースから提供されていません。運用会社のページをご確認ください |
| 直近の権利落ち日 | Sep 15, 2026 | 直近の分配金支払い | $0.0112 (Sep 18, 2026) |
| 1年成長率 | +27.60% | 3年／5年成長率（年率換算） | +1.51% / -0.20% |
| 権利落ち日 | 基準日 | 支払日 | 金額 |
|---|---|---|---|
| Sep 15, 2026 | Sep 15, 2026 | Sep 18, 2026 | $0.0112 |
| Jun 15, 2026 | Jun 15, 2026 | Jun 18, 2026 | $0.0238 |
| Mar 17, 2026 | Mar 17, 2026 | Mar 20, 2026 | $0.1218 |
| Dec 16, 2025 | Dec 16, 2025 | Dec 19, 2025 | $0.1831 |
| Sep 16, 2025 | Sep 16, 2025 | Sep 19, 2025 | $0.0828 |
| Mar 18, 2025 | Mar 18, 2025 | Mar 21, 2025 | $0.1212 |
| Dec 17, 2024 | Dec 17, 2024 | Dec 20, 2024 | $0.0624 |
| Sep 25, 2024 | Sep 25, 2024 | Sep 30, 2024 | $0.2005 |
| Mar 21, 2024 | Mar 22, 2024 | Mar 27, 2024 | $0.1260 |
| Dec 20, 2023 | Dec 21, 2023 | Dec 27, 2023 | $0.1240 |
| Sep 26, 2023 | Sep 27, 2023 | Oct 02, 2023 | $0.1532 |
| Jun 07, 2023 | Jun 08, 2023 | Jun 13, 2023 | $0.0062 |
直近12か月の分配金合計÷現在価格で算出した分配金利回り（トレーリング）。SEC 30日利回りとは異なり、分配金の継続は保証されません。 その差異の解説 →
リスク統計
| ボラティリティ 1年／3年 | 22.17% / 21.27% | シャープ（1年／3年） | 1.70 / 0.834 |
| 最大下落率 1年／3年 | -9.63% / -24.85% | ソルティノ（1年） | 2.71 |
| S&P 500対比ベータ（3年） | 0.806 | S&P 500との相関（1年） | 0.446 |
| 下方偏差（1年） | 13.88% | 使用無リスク金利 | 4.05% (3M T-bill, FRED) |
算出元： ETF Explorer 日次配当調整後終値を使用。ボラティリティおよびドローダウンは年率換算／期間数値。S&P 500エクスポージャーはSPYで代替。 時点 Oct 11, 2026. 計算式 →
流動性
| 本日の出来高 | 2.46M | 平均出来高 | 1.61M |
| AUM | $10.28B | プレミアム／ディスカウント | +2.85% |
| ビッド/アスクスプレッド | データソースから提供されていません。ご利用の証券会社の気配値画面をご確認ください。スプレッドは寄り付きと引け時点で最も拡大します。 | ||
プレミアム/ディスカウントは、遅延市場価格と直近報告NAVを比較した参考値であり、公式の終値プレミアム/ディスカウントではありません。 ETFの流動性の仕組み →
資金フロー（推計）
| 期間 | 推定純フロー | 開始時AUMの% | AUM（開始 → 終了） |
|---|---|---|---|
| 1日 | -$135.4M | -1.30% | $10.41B → $10.28B |
| 1ヶ月 | -$197.0M | -1.91% | $10.30B → $10.28B |
| 1週間 | -$456.3M | -4.28% | $10.67B → $10.28B |
ETF Explorerの推定値：独自の日次AUMスナップショットをもとに、報告AUMの変化から市場変動の影響を差し引いて算出。運用会社による公式の設定・解約データではありません。
ファンド公式資料
外部リンクは運用会社のサイトまたはSEC EDGARを新しいタブで開きます。目論見書および公式書類が常に正式な情報源です。投資前に必ずご確認ください。
最新ニュース： IBB
過去7日間にこのファンドに直接言及した記事はありません。ETF全般のニュースを表示しています。
3 Dividend ETFs to Buy at 40 and Never Sell Through Retirement ↗
Buying a dividend ETF at 40 and holding it until 80 sounds simple, but the fund that leads over one year consistently trails over ten, and the one…
24/7 Wall Street · Oct 11, 16:03 UTC
Should You Buy Bitcoin or XRP Right Now? The Case for Each ↗
Bitcoin and XRP have both taken hits lately, but the size of each coin's drop tells two very different stories about risk, recovery potential, and…
247 Wallst · Oct 11, 12:30 UTC
Same Age, Same Savings: Why One 59-Year-Old Collects $5,550 a Month for Life and the Other Doesn’t ↗
Two 59-year-olds hold the exact same six income funds at the exact same weights, yet one pays a federal penalty on every withdrawal while the other…
247 Wallst · Oct 11, 12:12 UTC
Sending an Adult Child $1,200 a Month at 70? That Is Money Leaving Every Month. These 3 ETFs Help Cover It Without Shrinking Principal ↗
Sending $1,200 a month to an adult child from the same account funding your retirement creates a slow drain most retirees don't notice until the…
247 Wallst · Oct 11, 12:03 UTC
Claude AI’s XRP Price Prediction: Will It Drop to $1.17 or Rise to $1.70 First? ↗
Anthropic's Claude AI ran the XRP chart data and landed on a definitive price target to watch first, and its reasoning hinges on a Bitcoin threshold…
247 Wallst · Oct 11, 12:00 UTC
Bitcoin, Ethereum, XRP, and Solana Are All Down in 2026. Which Has Held Up Best? ↗
All four major cryptocurrencies are bleeding in 2026, but the coin that looks strongest on paper may actually be in the worst shape of the group…
247 Wallst · Oct 11, 11:30 UTC
関連ニュース一覧： IBB →
使い方ガイド：AUMはファンドの規模です。経費率はリターンに織り込まれた年間コストです。NAVはファンドが保有する資産の1株当たり価値で、市場価格はNAVを若干上回る（プレミアム）または下回る（ディスカウント）場合があります。トータルリターンは分配金を再投資した前提で計算されています。保有銘柄・資産・価格はそれぞれ更新スケジュールが異なるため、データセットごとに基準日が表示されます。